CervoMed Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	8.32	9	7.79	4.09	6.67
Short-Term Investments	25.21	29.92	-	-	-
Cash & Short-Term Investments	33.53	38.92	7.79	4.09	6.67
Cash Growth	-25.64%	399.46%	90.37%	-38.59%	-
Accounts Receivable	2.36	2.25	0.92	-	-
Other Receivables	-	-	-	-	0.07
Receivables	2.36	2.25	0.92	-	0.07
Prepaid Expenses	1.96	1.91	1.26	0.06	0.02
Other Current Assets	0.22	-	-	-	0.05
Total Current Assets	38.08	43.08	9.96	4.16	6.82
Other Long-Term Assets	-	-	0.01	-	-
Total Assets	38.08	43.08	9.97	4.16	6.82
Accounts Payable	1.85	1.51	0.66	0.1	0.02
Accrued Expenses	2.71	2.25	1.84	0.59	0.4
Current Portion of Long-Term Debt	-	-	-	12.41	4.11
Other Current Liabilities	0.08	0.12	0.09	0.05	0.03
Total Current Liabilities	4.64	3.88	2.6	13.16	4.56
Long-Term Debt	-	-	-	-	5.92
Total Liabilities	4.64	3.88	2.6	13.16	10.47
Common Stock	0.01	0.01	0.01	0	0
Additional Paid-In Capital	115.32	109.87	61.81	18.98	18.52
Retained Earnings	-81.88	-70.73	-54.44	-52.27	-46.47
Comprehensive Income & Other	-0	0.06	-	-	-
Total Common Equity	33.44	39.2	7.38	-33.29	-27.94
Shareholders' Equity	33.44	39.2	7.38	-9	-3.66
Total Liabilities & Equity	38.08	43.08	9.97	4.16	6.82
Total Debt	-	-	-	12.41	10.03
Net Cash (Debt)	33.53	38.92	7.79	-8.32	-3.36
Net Cash Growth	-34.12%	399.46%	-	-	-
Net Cash Per Share	3.82	4.82	2.93	-16.06	-0.75
Filing Date Shares Outstanding	9.25	8.7	6.17	4.5	4.5
Total Common Shares Outstanding	9.25	8.7	5.67	4.5	4.5
Working Capital	33.44	39.2	7.37	-9	2.26
Book Value Per Share	3.61	4.50	1.30	-7.39	-6.21
Tangible Book Value	33.44	39.2	7.38	-33.29	-27.94
Tangible Book Value Per Share	3.61	4.50	1.30	-7.39	-6.21

Updated Aug 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q